# Low-Dose Atropine for Treatment of Myopia

> **NCT03334253** · PHASE3 · COMPLETED · sponsor: **Jaeb Center for Health Research** · enrollment: 200 (actual)

## Conditions studied

- Myopia

## Interventions

- **DRUG:** Atropine
- **OTHER:** Placebo Eyedrops

## Key facts

- **NCT ID:** NCT03334253
- **Lead sponsor:** Jaeb Center for Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-01
- **Primary completion:** 2022-04-15
- **Final completion:** 2022-09-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-09-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03334253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03334253, "Low-Dose Atropine for Treatment of Myopia". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03334253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*